CompaniesAlyssum Therapeutics
Alyssum Therapeutics logo

Alyssum Therapeutics

active
Cambridge, MA, United States
Founded 2018
Website
About

Small Molecule for Solid Malignancies

Areas of Focus

Categories

Small Molecule PharmaceuticalBoston & New England
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

85

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
NCT06234098
Hover over trial bars to see details

Recent Trials

NCT06234098Lead Sponsor
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
PHASE1/PHASE2Recruiting
85 participants
Started: Feb 13, 2024 · Completed: Jan 31, 2027
Locations (1)
Headquarters
Cambridge, MA, United States
Map

Loading map...